HWA
PCSA icon

Heritage Wealth Advisors’s Processa Pharmaceuticals PCSA Stock Holding History

Heritage Wealth Advisors’s Portfolio PCSA Stock Details PCSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-2
Closed -$8.57K – 549
2021
Q3 		$8.57K Hold
2
– – ﹤0.01% 443
2021
Q2 		$8.19K Hold
2
– – ﹤0.01% 456
2021
Q1 		$10.9K Buy
+2
New +$9.32K ﹤0.01% 461

Other funds holding PCSA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
SCM
Solas Capital Management Darien, Connecticut $174M AUM 6.33% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCA
Verdence Capital Advisors Hunt Valley, Maryland $1.72B AUM 24.88% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CBA
Coastal Bridge Advisors Westport, Connecticut $1.41B AUM 24.15% 1-Year Est. Return

Heritage Wealth Advisors's PCSA Position: Q4 2021 in Review

Heritage Wealth Advisors sold out of Processa Pharmaceuticals (PCSA) in Q4 2021, closing a stake of 2 shares — an estimated $8.57K sold.

Heritage Wealth Advisors first reported a position in PCSA in Q1 2021 and held it in 3 quarters. The position peaked at $10.9K in Q1 2021. 16 funds tracked by Wall St. Rank hold PCSA as of Q4 2021.

  • Heritage Wealth Advisors reported no remaining Processa Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • Heritage Wealth Advisors sold 2 Processa Pharmaceuticals shares in Q4 2021, an estimated $8.57K.
  • Heritage Wealth Advisors first reported a position in Processa Pharmaceuticals in Q1 2021 and held it in 3 quarters.
  • Heritage Wealth Advisors's Processa Pharmaceuticals position peaked at $10.9K in Q1 2021.
  • 16 funds tracked by Wall St. Rank held Processa Pharmaceuticals as of Q4 2021.

Based on Heritage Wealth Advisors's 13F filing for Q4 2021, filed 2 Feb 2022.